HEPATITIS D

Clinical trials for HEPATITIS D explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS D trials appear

Sign up with your email to follow new studies for HEPATITIS D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 2 Completed 1 Terminated 1

Hepatitis b drug trial halted midway

Disease control Terminated

This study tested an experimental drug called ARC-520 in 79 adults with chronic hepatitis B. Some participants received ARC-520 alone, while others got it with standard treatments like entecavir or tenofovir. The goal was to see if ARC-520 could lower hepatitis B surface antigen …

Matched conditions: HEPATITIS D

Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

HEPATITIS D

Get alerted when new HEPATITIS D trials appear

Hepatitis b drug trial halted midway